Muscle phosphofructokinase (PFK-M) deficiency (glycogenosis type VII,
Tarui's disease) is characterized by intolerance to vigorous exercise,
often accompanied by myoglobinuria. The disease is inherited as an au
tosomal recessive trait. The clinical manifestations are similar to th
ose in myophosphorylase deficiency (McArdle's disease), and the diagno
sis required demonstration of the enzyme defect in muscle biopsy. In t
he Western hemisphere PFK deficiency appears to be prevalent among peo
ple of Ashkenazi Jewish descent. To define the molecular basis of this
myopathy, we have studied 11 Ashkenazi and 2 non-Ashkenazi families w
ith the disease. Ashkenazi patients share two common pathogenic mutati
ons, a splicing defect and a nucleotide deletion, which account for si
milar to 95% of mutant alleles. The molecular diagnosis is now possibl
e in this population by using simple PCR-based tests to screen for the
se mutations. (C) 1995 John Wiley and Sons, Inc.